| Virucidal activity of World Health Organization–recommended formulations against enveloped viruses, including Zika, Ebola, and emerging coronaviruses A Siddharta, S Pfaender, NJ Vielle, R Dijkman, M Friesland, B Becker, ... The Journal of infectious diseases 215 (6), 902-906, 2017 | 257 | 2017 |
| Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs J Kronke, R Kittler, F Buchholz, MP Windisch, T Pietschmann, ... Journal of virology 78 (7), 3436-3446, 2004 | 243 | 2004 |
| Identification of type I and type II interferon‐induced effectors controlling hepatitis C virus replication P Metz, E Dazert, A Ruggieri, J Mazur, L Kaderali, A Kaul, U Zeuge, ... Hepatology 56 (6), 2082-2093, 2012 | 155 | 2012 |
| Mouse hepatic cells support assembly of infectious hepatitis C virus particles G Long, MS Hiet, MP Windisch, JY Lee, V Lohmann, R Bartenschlager Gastroenterology 141 (3), 1057-1066, 2011 | 117 | 2011 |
| Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line MP Windisch, M Frese, A Kaul, M Trippler, V Lohmann, R Bartenschlager Journal of virology 79 (21), 13778-13793, 2005 | 109 | 2005 |
| DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level C Ko, S Lee, MP Windisch, WS Ryu Journal of virology 88 (23), 13689-13698, 2014 | 92 | 2014 |
| Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19 M Ko, SY Chang, SY Byun, A Ianevski, I Choi, ... Viruses 13 (4), 651, 2021 | 90 | 2021 |
| Novel antiviral activities of obatoclax, emetine, niclosamide, brequinar, and homoharringtonine PI Andersen, K Krpina, A Ianevski, N Shtaida, E Jo, J Yang, S Koit, ... Viruses 11 (10), 964, 2019 | 88 | 2019 |
| Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2′-C-Methylcytidine, the Active Component of Valopicitabine L Coelmont, J Paeshuyse, MP Windisch, E De Clercq, R Bartenschlager, ... Antimicrobial agents and chemotherapy 50 (10), 3444-3446, 2006 | 88 | 2006 |
| Common nodes of virus–host interaction revealed through an integrated network analysis K Bösl, A Ianevski, TT Than, PI Andersen, S Kuivanen, M Teppor, RJ Cox, ... Frontiers in immunology 10, 453968, 2019 | 71 | 2019 |
| DDX60L is an interferon-stimulated gene product restricting hepatitis C virus replication in cell culture O Grünvogel, K Esser-Nobis, A Reustle, P Schult, B Müller, P Metz, ... Journal of virology 89 (20), 10548-10568, 2015 | 68 | 2015 |
| The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide C Ko, WJ Park, S Park, S Kim, MP Windisch, WS Ryu Antiviral therapy 20 (8), 835-842, 2015 | 67 | 2015 |
| Discovery and characterization of a novel 7-aminopyrazolo [1, 5-a] pyrimidine analog as a potent hepatitis C virus inhibitor JY Hwang, MP Windisch, S Jo, K Kim, S Kong, HC Kim, S Kim, H Kim, ... Bioorganic & medicinal chemistry letters 22 (24), 7297-7301, 2012 | 66 | 2012 |
| Automated genome-wide visual profiling of cellular proteins involved in HIV infection A Genovesio, YJ Kwon, MP Windisch, NY Kim, SY Choi, HC Kim, S Jung, ... Journal of biomolecular screening 16 (9), 945-958, 2011 | 65 | 2011 |
| Low oxygen tension enhances hepatitis C virus replication N Vassilaki, KI Kalliampakou, I Kotta-Loizou, C Befani, P Liakos, G Simos, ... Journal of virology 87 (5), 2935-2948, 2013 | 62 | 2013 |
| Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line S Haid, MP Windisch, R Bartenschlager, T Pietschmann Journal of virology 84 (2), 964-975, 2010 | 61 | 2010 |
| Identification and tracking of antiviral drug combinations A Ianevski, R Yao, S Biza, E Zusinaite, A Männik, G Kivi, A Planken, ... Viruses 12 (10), 1178, 2020 | 59 | 2020 |
| Efficient long-term amplification of hepatitis B virus isolates after infection of slow proliferating HepG2-NTCP cells A König, J Yang, E Jo, KHP Park, H Kim, TT Than, X Song, X Qi, X Dai, ... Journal of hepatology 71 (2), 289-300, 2019 | 57 | 2019 |
| Antiviral properties of chemical inhibitors of cellular anti-apoptotic Bcl-2 proteins D Bulanova, A Ianevski, A Bugai, Y Akimov, S Kuivanen, H Paavilainen, ... Viruses 9 (10), 271, 2017 | 44 | 2017 |
| Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase S Lee, KD Yoon, M Lee, Y Cho, G Choi, H Jang, BS Kim, DH Jung, JG Oh, ... British journal of pharmacology 173 (1), 191-211, 2016 | 40 | 2016 |
